{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:38:00Z","timestamp":1779003480526,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ajog.2005.11.030","type":"journal-article","created":{"date-parts":[[2006,4,25]],"date-time":"2006-04-25T02:11:30Z","timestamp":1145931090000},"page":"e23-e26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart"],"prefix":"10.1016","volume":"194","author":[{"given":"Youssef A.","family":"Rezk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata S.","family":"Balulad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.ajog.2005.11.030_bib1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.bjc.6601497","article-title":"Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies","volume":"89","author":"Vasey","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2005.11.030_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2005.11.030_bib3","first-page":"4766","article-title":"Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity","volume":"48","author":"Rajagopalan","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2005.11.030_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/20.2.237","article-title":"Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway","volume":"20","author":"Huang","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajog.2005.11.030_bib5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0022-5347(05)64739-8","article-title":"Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line","volume":"168","author":"Lin","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ajog.2005.11.030_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2004.02.031","article-title":"Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury","volume":"489","author":"Cao","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajog.2005.11.030_bib7","first-page":"2783","article-title":"Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies","volume":"24","author":"Aggarwal","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajog.2005.11.030_bib8","first-page":"H2916","article-title":"Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway","volume":"279","author":"Pham","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ajog.2005.11.030_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(93)90514-W","article-title":"Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)","volume":"46","author":"Sehested","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2005.11.030_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jn\/132.2.257","article-title":"The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful","volume":"132","author":"Juan","year":"2002","journal-title":"J Nutr"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805025615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805025615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T07:05:07Z","timestamp":1715929507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937805025615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0002937805025615"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2005.11.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2005.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}